查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2003124

機器人手術市場：按產品、技術、應用和最終用戶分類－2026年至2032年全球市場預測

Robotic Surgery Market by Product, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，機器人手術市場價值將達到 122.5 億美元，到 2026 年將成長到 138.6 億美元，到 2032 年將達到 302.6 億美元，複合年成長率為 13.78%。

主要市場統計數據
基準年 2025 122.5億美元
預計年份：2026年 138.6億美元
預測年份 2032 302.6億美元
複合年成長率 (%) 13.78%

簡要概述機器人手術如何發展成為一項核心臨床和商業性能力，並正在重塑外科手術實踐和醫療保健策略。

機器人手術已從實驗性的輔助工具發展成為重塑現代外科醫學的核心治療方法。這項技術的提案在於其更高的精準度、更小的創傷性以及在不同解剖專科領域實現可重複的治療效果。近期發展拓展了其臨床應用範圍，使其能夠開展心胸外科、泌尿系統、婦科和腫瘤科等複雜手術，同時改善手術環境，減輕外科醫生在長時間手術中的疲勞。

平台多元化、人工智慧驅動的視覺化和捆綁式服務模式如何重新定義機器人手術的臨床工作流程和商業策略。

在機器人手術領域，隨著技術和操作優勢的融合，一場變革正在發生。首先，平台多樣化正在加速。除了傳統的多臂系統外，強調小切口和簡化器械包的單孔單臂架構也日益普及。與硬體的演進相輔相成的是，模組化器械和能量設備能夠實現更個人化的手術組合，減少器械更換頻率，並提高手術流程的連續性。

2025 年貿易措施對整個機器人手術價值鏈的供應韌性、籌資策略和策略設計選擇所產生的連鎖影響。

2025年實施新關稅的政策決定對整個機器人手術生態系統產生了多方面的連鎖反應。依賴全球採購零件的製造商被迫重組供應鏈，以維持成本可預測性和生產連續性。為此，多家公司正在推廣在地採購、雙重採購安排和策略性庫存緩衝，以減輕短期中斷的影響。這些調整正在影響前置作業時間、資金配置以及與供應商的關係。

以細分市場為中心的洞察，展示了產品架構、臨床專科、最終用戶優先級和移植技術如何結合起來，從而決定部署和商業策略。

穩健的細分觀點揭示了產品、應用、終端用戶和技術層面的顯著趨勢，為商業化策略提供了直接的洞察。在產品層面，內視鏡攝影機、EndoWrist設備、能量設備和手術縫合器等儀器和配件會影響單次手術成本結構和臨床應用能力。諮詢、維護和培訓等服務逐漸成為重要的收入來源和客戶維繫工具，有助於臨床應用和設備運作。系統本身可分為適用於複雜多方面手術的多臂架構和旨在簡化工作流程和特定手術類型的單臂配置。

區域分析揭示了支付方模式、臨床培訓系統和本地製造如何影響部署模式和投資重點。

區域趨勢帶來了獨特的機會和挑戰，塑造了創新和應用加速發展的領域。在美洲，醫療服務提供者網路和私人醫療系統正在推動對能夠提供可預測結果和高效處理能力的整合平台的需求。該地區的報銷環境和資本化模式影響醫療服務提供者如何平衡初始部署成本與終身服務和耗材成本，而臨床促進者往往在採購決策中起著決定性作用。

競爭和公司趨勢表明，平台生態系統、智慧財產權策略和售後服務將如何決定機器人手術領域的長期領導地位。

機器人手術領域的競爭動態由平台生態系統、智慧財產權以及硬體差異化與軟體驅動服務之間的平衡所決定。市場領導透過結合已驗證的臨床成果、豐富的部署經驗和成熟的培訓系統來保持優勢。這些成熟企業受益於與大型醫療中心建立的長期合作關係、完善的服務網路以及能夠產生持續收入的耗材生態系統。

加強機器人手術供應鏈韌性、加快臨床醫生採用機器人手術技術以及實現以服務為導向的經營模式盈利，對高管而言是一項切實可行的戰略挑戰。

在機器人手術領域不斷發展的今天，領導者應採取一套優先且切實可行的策略，將臨床價值與永續的商業模式結合。首先，他們應從產品開發的早期階段就融入「成本意識設計」原則，減少對價格敏感型組件的依賴，並降低單次手術的耗材用量。這種方法能夠提升採購競爭力，並支持醫療機構更可預測的營運。其次，他們應投資於全面的培訓和認證項目，將基於模擬的課程與監考和遠端指導相結合，以加速安全部署，並在臨床環境中培養推廣意識。

一個綜合性的多方法研究框架，結合了來自臨床醫生的原始資訊、綜合性的二手證據和有針對性的案例研究，以檢驗實際的商業性見解。

本報告的分析整合了多方法研究框架，旨在確保研究結果的穩健性、相關性和可操作性。主要研究包括與臨床負責人、採購主管和工程專業人員進行結構化訪談，使研究結果立足於實際營運情況和臨床醫生的偏好。此外，專家小組和諮詢活動也為這些訪談提供了補充，從而對新出現的主題進行了反覆檢驗，尤其是在臨床工作流程、培訓路徑和售後服務期望方面。

本文簡要概述了技術創新、供應鏈韌性和以服務為中心的商業化如何共同決定機器人手術的持續成功。

總而言之，機器人手術領域正朝著更多元化、服務導向的生態系統發展，設備功能、耗材成本效益和軟體驅動型服務共同決定臨床應用和商業性成功。技術進步——尤其是單孔架構、影像技術和人工智慧輔助技術——正在重新定義手術的可能性，同時也正在改變醫療系統評估投資的標準。同時，政策轉變和貿易措施凸顯了供應鏈韌性和合約創新的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：機器人手術市場：依產品分類

  • 設備和配件
    • 內視鏡攝影機
    • MenoWrist 設備
    • 能源設備
    • 手術縫合器
  • 服務
    • 諮詢
    • 維護/修理
    • 培訓和教育
  • 系統
    • 多臂系統
    • 單臂系統

第9章：機器人手術市場：依技術分類

  • 多埠
  • 單埠
    • 達文西SP平台
    • 下一代系統

第10章：機器人手術市場：依應用領域分類

  • 心胸外科
  • 一般外科
  • 婦科
  • 神經外科
  • 整形外科
  • 泌尿系統

第11章：機器人手術市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第12章：機器人手術市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：機器人手術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：機器人手術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國機器人手術市場

第16章：中國機器人手術市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AiM Medical robots
  • Asensus Surgical, Inc.
  • Astrek Innovations
  • Auris Surgical Robotics
  • CMR Surgical Ltd
  • Comofi Medtech
  • Curneu
  • DiFACTO Robotics and Automation
  • Galen Robotics, Inc.
  • Globus Medical, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • Makers Hive Innovations
  • Medtronic plc
  • Monteris Medical
  • Noah Medical
  • Renishaw plc
  • Smith & Nephew plc
  • SS Innovations International
  • Stryker Corporation
  • Stryker India Pvt. Ltd.
  • Theranautilus
  • Titan Medical Inc.
  • Transenterix Surgical, Inc
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-AD517FAA88BA

The Robotic Surgery Market was valued at USD 12.25 billion in 2025 and is projected to grow to USD 13.86 billion in 2026, with a CAGR of 13.78%, reaching USD 30.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.25 billion
Estimated Year [2026] USD 13.86 billion
Forecast Year [2032] USD 30.26 billion
CAGR (%) 13.78%

A concise primer on how robotic surgery evolved into a core clinical and commercial capability reshaping procedural practice and institutional strategy

Robotic surgery has matured from an experimental adjunct into a core modality reshaping modern operative care. The technology's value proposition rests on improving precision, reducing invasiveness, and supporting reproducible outcomes across varied anatomical specialties. Recent developments have broadened the clinical envelope, enabling complex procedures in cardiothoracic, urologic, gynecologic, and oncologic care while simultaneously enhancing surgeon ergonomics and reducing fatigue during lengthy interventions.

Adoption drivers extend beyond raw device capability. Hospital leaders and ambulatory surgical centers now weigh total procedural efficiency, consumable and service economics, and integration with digital health systems when evaluating investments. Surgeons increasingly demand platforms that offer intuitive control, rapid turnover between cases, and a clear pathway to validated clinical benefits. Training and credentialing frameworks are evolving in parallel to ensure safe and efficient dissemination of robotic techniques, with simulation, proctoring, and structured curricula becoming standard components of adoption strategies.

As regulatory scrutiny and payer interest increase, clinical evidence and real-world outcomes play a central role in adoption decisions. Concurrently, competition is catalyzing innovation across hardware, instruments, and software layers. This convergence of clinical need, commercial pressure, and technological advancement is accelerating the transition of robotic surgery from a specialized capability to an integral element of contemporary surgical practice.

How platform diversification, AI-driven visualization, and bundled service models are collectively redefining clinical workflows and commercial strategies in robotic surgery

The landscape of robotic surgery is experiencing transformative shifts driven by converging technological and operational forces. First, platform diversification has accelerated: legacy multi-arm systems coexist increasingly with single-port and single-arm architectures that prioritize smaller incisions and streamlined tray sets. Complementing hardware evolution, modular instruments and energy devices are enabling more tailored procedural combinations that reduce instrument exchanges and improve workflow continuity.

Artificial intelligence and advanced imaging are becoming embedded features rather than optional add-ons. These capabilities support intraoperative guidance, augmented visualization, and predictive analytics that optimize decision-making in real time. As a result, clinical teams can expect shorter learning curves for selected procedures, improved margin delineation in oncologic cases, and enhanced tissue-sparing approaches. Simultaneously, digital ecosystems around robotics-covering tele-mentoring, remote proctoring, and cloud-based analytics-are expanding the ability to scale expertise across geographies.

Commercially, there is a clear pivot toward comprehensive service offerings that bundle devices with training, maintenance, and outcome-oriented service-level agreements. This shift reflects providers' desire to manage total cost of care and reduce operational friction. The competitive field is also becoming more fluid as new entrants challenge incumbent platforms with differentiated value propositions, and as partnerships between device makers and software companies blur traditional vendor boundaries. These shifts are reshaping procurement criteria, clinical pathways, and long-term strategic planning for providers and manufacturers alike.

The cascading consequences of 2025 trade measures on supply resilience, procurement tactics, and strategic design choices across the robotic surgery value chain

The policy decision to apply new tariffs in 2025 has produced a multifaceted ripple effect across the robotic surgery ecosystem. Manufacturers dependent on globally sourced components have had to reassess supply chain architectures to maintain cost predictability and production continuity. In response, several firms have pursued component localization, dual-sourcing arrangements, and strategic inventory buffering to mitigate near-term disruption. These adjustments have implications for lead times, capital allocation, and supplier relationships.

Hospitals and ambulatory surgical centers have exhibited increased scrutiny of total procurement costs, including not only device list prices but also the downstream effect on consumables, maintenance contracts, and service agreements. Procurement teams are negotiating more complex contracts, emphasizing risk-sharing constructs and performance-linked terms to retain fiscal flexibility. At the same time, regional purchasing consortia and group purchasing organizations have intensified collaboration to pool volume and manage tariff-driven cost pressure across networks.

From an innovation perspective, tariffs have encouraged manufacturers to evaluate manufacturing footprints, accelerate modular designs that reduce dependence on tariff-exposed parts, and explore aftersales service models that emphasize software and training revenue streams less sensitive to trade measures. Clinicians and health systems have responded by prioritizing devices that minimize per-case consumable intensity and by expanding in-house maintenance capabilities to control ongoing operational costs. Overall, the tariff environment has increased the premium on supply chain resilience, contractual creativity, and design approaches that reduce exposure to trade fluctuations.

Segment-focused insights showing how product architectures, clinical specialties, end user priorities, and port technologies jointly dictate adoption and commercial strategy

A robust segmentation lens reveals differentiated dynamics across product, application, end user, and technology dimensions that directly inform commercialization strategies. In the product dimension, instruments and accessories such as endoscopic cameras, EndoWrist instruments, energy devices, and surgical staplers influence per-procedure cost structures and clinical capability. Services including consulting, maintenance and repair, and training and education have emerged as critical revenue and retention levers that support clinical adoption and operational uptime. Systems themselves bifurcate into multi-arm architectures suited to complex, multi-quadrant procedures and single-arm configurations that target streamlined workflows and specific procedure types.

Application segmentation surfaces distinct clinical and purchasing behaviors across cardiothoracic surgery, general surgery, gynecology, neurosurgery, orthopedics, and urology. Each specialty manifests different instrumentation requirements, evidence thresholds, and throughput expectations, which in turn shape product roadmaps and outreach priorities. End users are concentrated in hospitals and ambulatory surgical centers, with the former emphasizing comprehensive capability and the latter prioritizing short-stay efficiency and cost per case. Technology segmentation highlights multi-port platforms alongside single-port systems; the Single-Port category includes established platforms such as the Da Vinci SP Platform as well as next-generation single-port systems that emphasize reduced incisional footprint and faster patient recovery.

Taken together, these segmentation axes demonstrate that successful market approaches require a coordinated strategy across device architecture, consumable economics, clinical evidence generation, and aftermarket services. Companies that align product design with specialty-specific workflows and end-user operational imperatives will be better positioned to capture durable clinical adoption and sustainable commercial traction.

Region-by-region intelligence revealing how payer models, clinical training capacity, and local manufacturing influence adoption patterns and investment priorities

Geographic dynamics present distinct opportunities and constraints that are shaping where innovation and adoption accelerate. In the Americas, provider networks and private health systems are driving demand for integrated platforms that deliver predictable outcomes and efficient throughput. Reimbursement environments and capital acquisition models in this region influence how providers balance upfront acquisition against lifetime service and consumable costs, and clinical champions often play a decisive role in procurement decisions.

Across Europe, the Middle East & Africa, reimbursement variability and regulatory heterogeneity create a patchwork of adoption pathways. Several advanced healthcare systems on the European continent emphasize robust clinical evidence and cost-effectiveness assessments prior to large-scale deployments, while markets in the Middle East are investing in flagship centers of excellence as hubs for advanced surgical care. In parts of Africa, constrained infrastructure and workforce shortages have led stakeholders to prioritize simple, cost-effective solutions and remote training models that can extend surgical capacity.

The Asia-Pacific region is characterized by a combination of rapid adoption in select markets and burgeoning local innovation. Large hospital systems and national health initiatives are supporting the diffusion of robotic platforms, while a growing number of domestic manufacturers are introducing competitive alternatives. Training capacity, surgeon density, and procedural demand trajectories vary widely across the region, and strategic market entry requires tailored approaches that consider regulatory timelines, local reimbursement policies, and the importance of post-sale support networks.

Competitive and corporate dynamics demonstrating how platform ecosystems, IP strategies, and aftermarket services determine long-term leadership in robotic surgery

Competitive dynamics in the robotic surgery domain are defined by platform ecosystems, intellectual property, and the balance between hardware differentiation and software-enabled services. Market leaders maintain advantages where they couple validated clinical outcomes with extensive installed bases and mature training infrastructures. These incumbents benefit from durable relationships with high-volume surgical centers, integrated service networks, and consumable ecosystems that generate recurring revenue.

At the same time, a vigorous wave of challengers and adjacent-technology firms are introducing targeted innovations that pressure incumbents on cost, user experience, and procedural flexibility. New entrants often focus on niche clinical use cases, simplified interfaces, or lower-cost consumable models to gain initial traction. Strategic partnerships between device manufacturers and software companies are increasingly common, aimed at delivering integrated visualization, analytics, and remote support capabilities that extend the value proposition beyond the physical platform.

Mergers, acquisitions, and collaborative development agreements are active levers companies use to accelerate capability gaps and expand portfolios. Aftermarket services including maintenance contracts, training programs, and consumable supply chains are pivotal to customer retention and lifetime value. For investors and corporate strategists, the critical questions revolve around platform scalability, the defensibility of software and IP, and the ability to cultivate clinical champions who will advocate for long-term adoption within health systems.

Practical strategic imperatives for executives to fortify supply resilience, accelerate clinician uptake, and monetize service-oriented business models in robotic surgery

Leaders seeking to navigate the evolving robotic surgery landscape should adopt a set of prioritized, actionable strategies that align clinical value with durable commercial models. First, design-to-cost principles should be embedded early in product development to reduce dependence on tariff-exposed components and to lower per-case consumable intensity. This approach enhances procurement competitiveness and supports more predictable operations for providers. Second, invest in comprehensive training and credentialing programs that pair simulation-based curricula with proctoring and remote mentoring to accelerate safe adoption and build clinical advocates.

Third, develop bundled service offerings that integrate maintenance, consumables, and outcome-oriented performance guarantees; such bundles reduce hidden operational friction for end users and create recurring revenue streams. Fourth, expand digital capabilities by integrating advanced imaging, AI-assisted decision support, and cloud analytics to differentiate on both clinical outcomes and operational insights. Fifth, pursue strategic partnerships that complement core hardware with software, data services, and regional distribution strength to accelerate market access.

Finally, engage proactively with regulators and payers to align evidence generation with reimbursement pathways, prioritizing high-impact indications where clinical benefit is most clearly demonstrated. By focusing on supply resilience, training excellence, service-led commercial models, and evidence-aligned commercialization, leaders can convert technological advantage into sustainable clinical adoption and financial performance.

An integrated, multi-method research framework combining primary clinician input, secondary evidence synthesis, and targeted case studies to validate practical commercial insights

The analysis underpinning this report integrates a multi-method research framework designed to ensure robustness, relevance, and practical applicability. Primary research included structured discussions with clinical leaders, procurement executives, and engineering specialists to ground findings in operational realities and clinician preferences. These interviews were complemented by expert panels and advisory engagements that provided iterative validation of emergent themes, particularly around clinical workflows, training pathways, and aftersales expectations.

Secondary research synthesized peer-reviewed clinical literature, regulatory filings, and publicly available technical documentation to triangulate device capabilities and evidence profiles. Case studies of exemplar institutions were assembled to illustrate adoption pathways, staffing models, and integration with hospital information systems. Supply chain and procurement observations derived from vendor disclosures and public procurement records informed assessments of manufacturing footprint, component sourcing strategies, and contractual trends.

Finally, cross-validation and internal peer review were applied to ensure coherence across segmentation, regional dynamics, and company-level insights. The methodology prioritized transparency in assumptions and traceability to source material, with a focus on translating technical and clinical signals into actionable commercial recommendations for industry stakeholders.

Concise synthesis of how technological innovation, supply resilience, and service-centric commercialization collectively determine durable success in robotic surgery

In summary, the robotic surgery sector is transitioning into a more heterogeneous and service-oriented ecosystem where device capability, consumable economics, and software-enabled services jointly determine clinical adoption and commercial success. Technological advances-particularly in single-port architectures, imaging, and AI-driven assistance-are redefining procedural possibilities while also shifting the criteria by which health systems evaluate investments. Concurrently, policy shifts and trade measures have underscored the importance of supply chain resilience and contract innovation.

Providers and manufacturers that align product design with specialty-specific workflows, invest in comprehensive training and aftersales support, and demonstrate clear clinical value will be best positioned to sustain adoption. Competitive advantage increasingly depends on building platform ecosystems that combine hardware excellence with software-driven insights and predictable service delivery. Strategic partnerships and targeted clinical evidence programs will accelerate market access in geographies with diverse regulatory and reimbursement environments.

Ultimately, the most successful stakeholders will be those that can translate technical innovation into measurable clinical benefit and operational efficiency, while managing commercial complexity through flexible contracts, resilient sourcing strategies, and an unwavering focus on clinician training and patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Robotic Surgery Market, by Product

  • 8.1. Instruments And Accessories
    • 8.1.1. Endoscopic Cameras
    • 8.1.2. EndoWrist Instruments
    • 8.1.3. Energy Devices
    • 8.1.4. Surgical Staplers
  • 8.2. Services
    • 8.2.1. Consulting
    • 8.2.2. Maintenance And Repair
    • 8.2.3. Training And Education
  • 8.3. Systems
    • 8.3.1. Multi-Arm System
    • 8.3.2. Single-Arm System

9. Robotic Surgery Market, by Technology

  • 9.1. Multi-Port
  • 9.2. Single-Port
    • 9.2.1. Da Vinci SP Platform
    • 9.2.2. Next Generation Systems

10. Robotic Surgery Market, by Application

  • 10.1. Cardiothoracic Surgery
  • 10.2. General Surgery
  • 10.3. Gynecology
  • 10.4. Neurosurgery
  • 10.5. Orthopedics
  • 10.6. Urology

11. Robotic Surgery Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Robotic Surgery Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Robotic Surgery Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Robotic Surgery Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Robotic Surgery Market

16. China Robotic Surgery Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AiM Medical robots
  • 17.6. Asensus Surgical, Inc.
  • 17.7. Astrek Innovations
  • 17.8. Auris Surgical Robotics
  • 17.9. CMR Surgical Ltd
  • 17.10. Comofi Medtech
  • 17.11. Curneu
  • 17.12. DiFACTO Robotics and Automation
  • 17.13. Galen Robotics, Inc.
  • 17.14. Globus Medical, Inc.
  • 17.15. Intuitive Surgical, Inc.
  • 17.16. Johnson & Johnson Services, Inc.
  • 17.17. Makers Hive Innovations
  • 17.18. Medtronic plc
  • 17.19. Monteris Medical
  • 17.20. Noah Medical
  • 17.21. Renishaw plc
  • 17.22. Smith & Nephew plc
  • 17.23. SS Innovations International
  • 17.24. Stryker Corporation
  • 17.25. Stryker India Pvt. Ltd.
  • 17.26. Theranautilus
  • 17.27. Titan Medical Inc.
  • 17.28. Transenterix Surgical, Inc
  • 17.29. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ROBOTIC SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ROBOTIC SURGERY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ROBOTIC SURGERY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ROBOTIC SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ROBOTIC SURGERY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ROBOTIC SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ENDOSCOPIC CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ENDOSCOPIC CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ENDOSCOPIC CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ENDOWRIST INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ENDOWRIST INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ENDOWRIST INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SURGICAL STAPLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SURGICAL STAPLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SURGICAL STAPLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY MAINTENANCE AND REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY MAINTENANCE AND REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY MAINTENANCE AND REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY TRAINING AND EDUCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY TRAINING AND EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY TRAINING AND EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY MULTI-ARM SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY MULTI-ARM SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY MULTI-ARM SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SINGLE-ARM SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SINGLE-ARM SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SINGLE-ARM SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY MULTI-PORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY MULTI-PORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY MULTI-PORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY DA VINCI SP PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY DA VINCI SP PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY DA VINCI SP PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS ROBOTIC SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ROBOTIC SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GCC ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 167. GCC ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 168. GCC ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. GCC ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 170. GCC ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. GCC ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 172. GCC ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. GCC ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. G7 ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 194. G7 ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 195. G7 ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. G7 ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 197. G7 ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. G7 ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 199. G7 ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. G7 ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. NATO ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 203. NATO ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 204. NATO ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 205. NATO ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 206. NATO ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. NATO ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 208. NATO ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. NATO ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES ROBOTIC SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA ROBOTIC SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA ROBOTIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA ROBOTIC SURGERY MARKET SIZE, BY INSTRUMENTS AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA ROBOTIC SURGERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA ROBOTIC SURGERY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA ROBOTIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA ROBOTIC SURGERY MARKET SIZE, BY SINGLE-PORT, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA ROBOTIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA ROBOTIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)